PharmaCyte Biotech Inc. (PMCB)
NASDAQ: PMCB
· Real-Time Price · USD
0.96
0.03 (2.81%)
At close: Sep 05, 2025, 3:58 PM
0.97
0.91%
Pre-market: Sep 08, 2025, 04:06 AM EDT
2.81% (1D)
| Bid | 0.95 |
| Market Cap | 6.55M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | 30.66M |
| EPS (ttm) | 3.1 |
| PE Ratio (ttm) | 0.31 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.98 |
| Volume | 7,074 |
| Avg. Volume (20D) | 52,720 |
| Open | 0.98 |
| Previous Close | 0.93 |
| Day's Range | 0.94 - 0.98 |
| 52-Week Range | 0.80 - 2.42 |
| Beta | -0.24 |
About PMCB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PMCB
Website n/a
2 weeks ago · businesswire.com
PharmaCyte Biotech, Inc. Announces Closing of $7 Million FinancingLAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the closing of its previously announced $7 million financing. As of April 30, 2025, ...
